A BILL 
To amend the Public Health Service Act to expand, enhance, 
and improve applicable public health data systems used 
by the Centers for Disease Control and Prevention, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Ensuring Transparent 
4
Honest Information on COVID–19 Act’’ or the ‘‘ETHIC 
5
Act’’. 
6
03:17 Mar 06, 2021
H976
2 
•HR 976 IH
SEC. 2. REQUIRED REPORTING BY STATE, LOCAL, TRIBAL, 
1
OR TERRITORIAL GOVERNMENTS REGARD-
2
ING COVID–19. 
3
(a) IN GENERAL.—As a condition on receipt of funds 
4
through a covered grant or cooperative agreement, a 
5
State, local, Tribal, or Territorial government shall agree 
6
to direct the appropriate State, local, Tribal, or Territorial 
7
governmental entity (including any public health depart-
8
ment thereof) to report to the Centers for Disease Control 
9
and Prevention, with respect to the jurisdiction involved 
10
and COVID–19— 
11
(1) on a daily basis, the information listed in 
12
subsection (d); and 
13
(2) on a weekly basis, the information listed in 
14
subsection (e). 
15
(b) TRIBAL WAIVER.— 
16
(1) REVIEW AND DISPOSITION.—Upon the re-
17
ceipt of a written request from a Tribal government, 
18
or consortia thereof, for a waiver of the conditions 
19
specified in paragraphs (1) and (2) of subsection 
20
(a), the Director of the Centers for Disease Control 
21
and Prevention shall, not later than 30 days after 
22
receipt of such request, approve or deny it. 
23
(2) DENIALS.—In the case of a denial of a re-
24
quest under paragraph (1), the Director of the Cen-
25
ters for Disease Control and Prevention shall— 
26
03:17 Mar 06, 2021
H976
3 
•HR 976 IH
(A) provide to the requestor a written ex-
1
planation of the reasons for the denial; and 
2
(B) provide the requestor with an oppor-
3
tunity to correct any deficiencies in the request. 
4
(c) COVERED GRANT
OR COOPERATIVE AGREE-
5
MENT.—For purposes of this section, a covered grant or 
6
cooperative agreement is any grant or cooperative agree-
7
ment awarded under any of the following laws (including 
8
any amendment made thereby): 
9
(1) The Coronavirus Preparedness and Re-
10
sponse Supplemental Appropriations Act, 2020 
11
(Public Law 116–123). 
12
(2) The Families First Coronavirus Response 
13
Act (Public Law 116–127). 
14
(3) The CARES Act (Public Law 116–136). 
15
(4) The Paycheck Protection Program and 
16
Health Care Enhancement Act (Public Law 116– 
17
139). 
18
(5) The Consolidated Appropriations Act, 2021 
19
(Public Law 116–260). 
20
(d) DAILY REPORTING.—The information to be re-
21
ported daily pursuant to subsection (a)(1) consists of the 
22
following, disaggregated to the county level if applicable: 
23
(1) Demographic characteristics, including, in a 
24
de-identified, disaggregated, and stratified manner, 
25
03:17 Mar 06, 2021
H976
4 
•HR 976 IH
race, ethnicity, age, sex, geographic region, and 
1
other relevant factors of individuals tested for or di-
2
agnosed with COVID–19, to the extent such infor-
3
mation is available. 
4
(2) The number of adults with a confirmed case 
5
of COVID–19 who are hospitalized in an intensive 
6
care bed. 
7
(3) The number of adults with a suspected case 
8
of COVID–19 who are hospitalized in an intensive 
9
care bed. 
10
(4) The number of adults with a confirmed case 
11
of COVID–19 who are hospitalized in an inpatient 
12
care bed. 
13
(5) The number of adults with a suspected case 
14
of COVID–19 who are hospitalized in an inpatient 
15
care bed. 
16
(6) The number of children with a confirmed 
17
case of COVID–19 who are hospitalized in an inten-
18
sive care bed. 
19
(7) The number of children with a suspected 
20
case of COVID–19 who are hospitalized in an inten-
21
sive care bed. 
22
(8) The number of children with a confirmed 
23
case of COVID–19 who are hospitalized in an inpa-
24
tient care bed. 
25
03:17 Mar 06, 2021
H976
5 
•HR 976 IH
(9) The number of children with a suspected 
1
case of COVID–19 who are hospitalized in an inpa-
2
tient care bed. 
3
(10) Out of the maximum number of beds for 
4
which hospitals are licensed to operate, the percent-
5
age occupied by confirmed or suspected COVID–19 
6
patients. 
7
(11) Total staffed hospital beds. 
8
(12) The numbers of diagnostic and serological 
9
tests administered for COVID–19, disaggregated 
10
and stratified by— 
11
(A) the type of test (molecular and anti-
12
gen); and 
13
(B) the testing positivity rate of each type 
14
of test. 
15
(13) The median turnaround time for diag-
16
nostic tests stratified by molecular and antigen tests. 
17
(14) The percentage of new cases of COVID– 
18
19 linked to at least one other case and, if such new 
19
cases are part of a known outbreak, identification of 
20
such outbreak. 
21
(15) The rate of transmission of COVID–19. 
22
(16) The number of confirmed and probable 
23
deaths as a result of COVID–19, de-identified and 
24
03:17 Mar 06, 2021
H976
6 
•HR 976 IH
stratified by race, ethnicity, age, sex, geographic re-
1
gion, and other relevant factors. 
2
(17) The number of residents in nursing homes 
3
and assisted living facilities with a suspected or con-
4
firmed case of COVID–19. 
5
(18) The number of residents in nursing homes 
6
and assisted living facilities who have died from 
7
COVID–19. 
8
(19) The number of staff in nursing homes and 
9
assisted living facilities with a suspected or con-
10
firmed case of COVID–19. 
11
(20) Such other information as the Director of 
12
the Centers for Disease Control and Prevention 
13
deems to be relevant. 
14
(e) WEEKLY REPORTING.—The information to be re-
15
ported weekly pursuant to subsection (a)(2) consists of the 
16
following, disaggregated to the county level if applicable: 
17
(1) New infections of health care workers not 
18
confirmed to have contracted COVID–19 outside of 
19
the workplace. 
20
(2) The median time between collection of 
21
specimens for diagnostic tests for COVID–19 and 
22
isolation of cases. 
23
(3) The percentage of new cases of COVID–19 
24
among quarantined contacts. 
25
03:17 Mar 06, 2021
H976
7 
•HR 976 IH
(4) The following information, in a manner that 
1
is de-identified, and is disaggregated and stratified 
2
by race, ethnicity, age, sex, geographic region, and 
3
other relevant factors, to the extent such informa-
4
tion is available: 
5
(A) New suspected and confirmed cases of 
6
COVID–19 per 100,000 individuals. 
7
(B) The percent change in new suspected 
8
and confirmed cases of COVID–19 per 100,000 
9
individuals. 
10
(C) The number of COVID–19 vaccine 
11
doses administered. 
12
(D) The number of individuals receiving a 
13
first dose of COVID–19 vaccine. 
14
(E) The number of individuals completing 
15
a vaccination course for COVID–19. 
16
(5) The number of COVID–19 vaccine doses re-
17
ceived by the reporting State, local, Tribal, or Terri-
18
torial government, disaggregated by supplier. 
19
(6) The number of nursing home and assisted 
20
living residents who have received a first dose of 
21
COVID–19 vaccine. 
22
(7) The number of nursing home and assisted 
23
living residents who have completed a vaccination 
24
course for COVID–19. 
25
03:17 Mar 06, 2021
H976
8 
•HR 976 IH
(8) Such other information as the Director of 
1
the Centers for Disease Control and Prevention 
2
deems to be relevant. 
3
(f) PUBLIC POSTING OF REPORTED DATA.—On a 
4
daily basis, the Director of the Centers for Disease Control 
5
and Prevention shall make the information reported pur-
6
suant to this section, excluding personally identifiable in-
7
formation, publicly available on the website of the Centers 
8
for Disease Control and Prevention. 
9
(g) APPLICABILITY.—The condition on funding in 
10
subsection (a) applies with respect to the obligation and 
11
expenditure by the Federal Government of funds through 
12
a covered grant or cooperative agreement on or after the 
13
date of enactment of this Act, including with respect to 
14
covered grants and cooperative agreements awarded before 
15
such date. 
16
SEC. 3. STUDY EXAMINING PUBLIC HEALTH DATA AND IN-
17
FRASTRUCTURE NECESSARY DURING AND 
18
AFTER THE COVID–19 PUBLIC HEALTH EMER-
19
GENCY. 
20
(a) IN GENERAL.—The Secretary of Health and 
21
Human Services (in this section referred to as the ‘‘Sec-
22
retary’’) shall seek to enter into a contract with the Na-
23
tional Academies of Sciences, Engineering, and Medicine 
24
(referred to in this section as the ‘‘National Academies’’) 
25
03:17 Mar 06, 2021
H976
9 
•HR 976 IH
not later than 30 days after the date of enactment of this 
1
Act, under which the National Academies agree to conduct 
2
a study with stakeholders from Federal agencies, State, 
3
Tribal, Territorial, and local governments, research insti-
4
tutions, industry, and nonprofit organizations that would 
5
review the current system for public health data infra-
6
structure and reporting and provide recommendations on 
7
needed data and system improvements for future 
8
pandemics and ongoing public health needs. 
9
(b) SUBMISSION OF REPORT.—The contract under 
10
subsection (a) shall require that the study under such sub-
11
section be completed, and a report on the resulting rec-
12
ommendations be submitted to the Secretary, the Com-
13
mittee on Health, Education, Labor, and Pensions of the 
14
Senate and the Committee on Energy and Commerce of 
15
the House of Representatives, not later than 12 months 
16
after the date the contract was executed. 
17
(c) STUDY TOPICS.—The contract under subsection 
18
(a) shall require the study under such subsection to— 
19
(1) review the current public health data sys-
20
tems and the reporting structure for Federal, State, 
21
Tribal, Territorial, and local public health informa-
22
tion, including vital records; 
23
(2) review current standards for reporting, 
24
quality controls, and transparency of the data; 
25
03:17 Mar 06, 2021
H976
10 
•HR 976 IH
(3) examine data gaps and barriers to timely 
1
and accurate reporting and identify ways to fill 
2
those gaps; 
3
(4) examine how systems can be accessed and 
4
used by a wide range of users, including external re-
5
searchers; 
6
(5) examine how different data systems interact 
7
and how different data sources can be integrated; 
8
(6) examine nontraditional data sources or al-
9
ternative data gathering methods that could be used 
10
to complement traditionally collected data; 
11
(7) identify needed improvements to the public 
12
health data systems and structure, especially with 
13
regard to the needs of Tribal systems; 
14
(8) identify core elements of a ‘‘minimum data 
15
set’’ that might be used for State population surveil-
16
lance, including demographic components that are 
17
necessary to ensure health equity in public health 
18
decision making; 
19
(9) examine how surveillance systems can be ex-
20
plicitly designed to ensure underserved populations 
21
(which may include racial and ethnic minorities, im-
22
migrants, individuals in nursing homes, other insti-
23
tutionalized populations, and individuals experi-
24
encing homelessness) are included in reporting; 
25
03:17 Mar 06, 2021
H976
11 
•HR 976 IH
(10) consider how traditional and nontradi-
1
tional data might be used to promote health equity 
2
across the United States and reduce racial, Tribal, 
3
and other demographic disparities; 
4
(11) examine data gaps and barriers to col-
5
lecting, analyzing, and using demographic data to 
6
characterize the COVID–19 pandemic for public 
7
health action and research to improve public health 
8
actions and identify ways to fill those gaps; and 
9
(12) report on what is known based on existing 
10
data about how COVID–19 is impacting subgroups 
11
of the population with respect to access to testing, 
12
treatment, and vaccination (hospitalization and ac-
13
cess to drugs and medical equipment), and health 
14
outcomes (morbidity and mortality). 
15
(d) DISAGGREGATION OF DATA.—To the extent fea-
16
sible, the contract under subsection (a) shall require data 
17
to be disaggregated by race, ethnicity, age, gender, dis-
18
ability, geography, language, socioeconomic status, and 
19
other factors. 
20
(e) AUTHORIZATION OF APPROPRIATIONS.—To carry 
21
out this section, there is authorized to be appropriated 
22
$1,000,000, to remain available until expended. 
23
Æ 
03:17 Mar 06, 2021
H976
